|
|
|
|
A nationwide Class I recall of Digitek (digoxin) was released as the product is considered extremely dangerous and may cause either death or serious injuries.
When a medication has been recalled and it is considered a Class I recall, it is important that there are many means in which this information is shared. An example is information about a very important recall of the drug known as Digitek (digoxin). There are numerous pharmaceutical companies across the United States and even more medications that are provided for patients all over America. It is difficult for people, without the help of their doctors, to be aware of all of the different medications, the changes in the medications they are using, as well as being informed about whether their medications have been recalled. A Class I RecallDigitek, also known as Digoxin, was voluntarily recalled by its manufacturer Actavis Totowa. The drug is distributed by Mylan Pharmaceuticals and sold under the label “Bertek” or by UDL Laboratories, INC, under a “UDL” label. This recall is a “Class I” recall, because the product is considered extremely dangerous and may cause either death or serious injury when used by consumers. This drug is very common and is often used for people dealing with either abnormal heart rhythms or congestive heart failure. People who have been prescribed the medication need to return all strengths of Digitek as soon as possible. The Reason for the Recall of DigitekUnfortunately, the manufacturer who released the product has produced an an unknown quantity of tablets with twice the approved level of the active ingredient (digoxin) in the drug. So far, there have been numerous reports of illness and injuries due to people unknowingly taking the double strength pill. For people with preexisting kidney problems, this is even more of a concern as it poses a risk for digitalis toxicity. The Side Effects of DigitekIf a person or a loved one has been prescribed Digitek and is experiencing any of the following side effects, he needs to contact a medical professional as soon as possible.
If a person has been taking Digitek for a long period of time and is not experiencing any of the aforementioned side effects it is still critical to contact his health care provider immediately to determine the appopriate course of action for his medical concerns.
The copyright of the article Recall of Digitek in Healthcare Research is owned by Laura Block-Stewart. Permission to republish Recall of Digitek in print or online must be granted by the author in writing.
|
|
|
|
|
|
|
|